|
1
|
Bennett JM, Catovsky D, Daniel MT,
Flandrin G, Galton DA, Gralnick HR and Sultan C: Proposals for the
classification of the acute leukaemias. French-American-British
(FAB) co-operative group. Br J Haematol. 33:451–458. 1976.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Imani-Saber Z and Ghafouri-Fard S:
Promyelocytic leukemia gene functions and roles in tumorigenesis.
Asian Pac J Cancer Prev. 15:8021–8028. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ganzel C and Douer D: Extramedullary
disease in APL: A real phenomenon to contend with or not? Best
Pract Res Clin Haematol. 27:63–68. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Sandhu S and Mulligan SP: Ofatumumab and
its role as immunotherapy in chronic lymphocytic leukemia.
Haematologica. 100:411–414. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chen SJ: A potential target of Tanshinone
IIA for acute promyelocytic leukemia revealed by inverse docking
and drug repurposing. Asian Pac J Cancer Prev. 15:4301–4305. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Liang H, Li X, Wang L, Yu S, Xu Z, Gu Y,
Pan Z, Li T, Hu M, Cui H, et al: MicroRNAs contribute to
promyelocyte apoptosis in As2O3-treated APL cells. Cell Physiol
Biochem. 32:1818–1829. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sharifi M, Salehi R, Gheisari Y and Kazemi
M: Inhibition of microRNA miR-92a induces apoptosis and inhibits
cell proliferation in human acute promyelocytic leukemia through
modulation of p63 expression. Mol Biol Rep. 41:2799–2808. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Tu K, Li C, Zheng X, Yang W, Yao Y and Liu
Q: Prognostic significance of miR-218 in human hepatocellular
carcinoma and its role in cell growth. Oncol Rep. 32:1571–1577.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang F, Ren X and Zhang X: Role of
microRNA-150 in solid tumors. Oncol Lett. 10:11–16. 2015.PubMed/NCBI
|
|
10
|
Zhao J, Lu Q, Zhu J, Fu J and Chen YX:
Prognostic value of miR-96 in patients with acute myeloid leukemia.
Diagn Pathol. 9:762014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang H, Luo XQ, Feng DD, Zhang XJ, Wu J,
Zheng YS, Chen X, Xu L and Chen YQ: Upregulation of microRNA-125b
contributes to leukemogenesis and increases drug resistance in
pediatric acute promyelocytic leukemia. Mol Cancer. 10:1082011.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Dong Y, Zou J, Su S, Huang H, Deng Y, Wang
B and Li W: MicroRNA-218 and microRNA-520a inhibit cell
proliferation by downregulating E2F2 in hepatocellular carcinoma.
Mol Med Rep. 12:1016–1022. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu YL, Jiang SX, Yang YM, Xu H, Liu JL
and Wang XS: USP22 acts as an oncogene by the activation of
BMI-1-mediated INK4a/ARF pathway and Akt pathway. Cell Biochem
Biophys. 62:229–235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Miftakhova R, Sandberg T, Hedblom A,
Nevzorova T, Persson JL and Bredberg A: DNA methylation in
ATRA-treated leukemia cell lines lacking a PML-RAR chromosome
translocation. Anticancer Res. 32:4715–4722. 2012.PubMed/NCBI
|
|
16
|
Liu WJ, Jiang NJ, Guo QL and Xu Q: ATRA
and As2O3 regulate differentiation of human
hematopoietic stem cells into granulocyte progenitor via alteration
of HoxB8 expression. Eur Rev Med Pharmacol Sci. 19:1055–1062.
2015.PubMed/NCBI
|
|
17
|
Yoshino H, Seki N, Itesako T, Chiyomaru T,
Nakagawa M and Enokida H: Aberrant expression of microRNAs in
bladder cancer. Nat Rev Urol. 10:396–404. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sharifi M, Salehi R, Gheisari Y and Kazemi
M: Inhibition of microRNA miR-92a induces apoptosis and inhibits
cell proliferation in human acute promyelocytic leukemia through
modulation of p63 expression. Mol Biol Rep. 41:2799–2808. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li Y, Zhu X, Gu J, Hu H, Dong D, Yao J,
Lin C and Fei J: Anti-miR-21 oligonucleotide enhances
chemosensitivity of leukemic HL60 cells to arabinosylcytosine by
inducing apoptosis. Hematology. 15:215–221. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cheng MW, Wang LL and Hu GY: Expression of
microRNA-218 and its clinicopathological and prognostic
significance in human glioma cases. Asian Pac J Cancer Prev.
16:1839–1843. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jin J, Cai L, Liu ZM and Zhou XS:
miRNA-218 inhibits osteosarcoma cell migration and invasion by
down-regulating of TIAM1, MMP2 and MMP9. Asian Pac J Cancer Prev.
14:3681–3684. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhang X, Tian T, Sun W, Liu C and Fang X:
Bmi-1 overexpression as an efficient prognostic marker in patients
with nonsmall cell lung cancer. Medicine (Baltimore). 96:e73462017.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin X, Ojo D, Wei F, Wong N, Gu Y and Tang
D: A novel aspect of tumorigenesis-BMI1 functions in regulating DNA
damage response. Biomolecules. 5:3396–3415. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meng S, Luo M, Sun H, Yu X, Shen M, Zhang
Q, Zhou R, Ju X, Tao W, Liu D, et al: Identification and
characterization of Bmi-1-responding element within the human p16
promoter. J Biol Chem. 285:33219–33229. 2010. View Article : Google Scholar : PubMed/NCBI
|
